|
ABT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.72955008490317E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
4.385200E-04 |
| Normal-vs-Stage3 |
8.59189996926801E-09 |
| Normal-vs-Stage4 |
6.14509999996571E-07 |
| Stage1-vs-Stage2 |
4.476100E-02 |
| Stage1-vs-Stage3 |
2.593900E-02 |
| Stage1-vs-Stage4 |
2.303900E-02 |
| Stage2-vs-Stage3 |
6.760400E-01 |
| Stage2-vs-Stage4 |
8.944600E-01 |
| Stage3-vs-Stage4 |
7.351600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.37345690376378E-12 |
| Normal-vs-AfricanAmerican |
7.26549931329146E-11 |
| Normal-vs-Asian |
1.116350E-02 |
| Caucasian-vs-AfricanAmerican |
9.986700E-04 |
| Caucasian-vs-Asian |
8.310400E-01 |
| AfricanAmerican-vs-Asian |
1.698330E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81360038098433E-10 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
8.0752999999989E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.481000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.66293670342566E-13 |
| Normal-vs-Age(61-80Yrs) |
2.58193466606826E-12 |
| Normal-vs-Age(81-100Yrs) |
2.191600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.563800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.958000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.658600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.104200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.507400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.877800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.63402624764331E-12 |
| Normal-vs-Grade 2 |
1.62458935193399E-12 |
| Normal-vs-Grade 3 |
1.44769995991112E-09 |
| Normal-vs-Grade 4 |
4.205900E-04 |
| Grade 1-vs-Grade 2 |
9.754600E-04 |
| Grade 1-vs-Grade 3 |
1.02950000002711E-06 |
| Grade 1-vs-Grade 4 |
3.00379999984557E-07 |
| Grade 2-vs-Grade 3 |
7.753800E-04 |
| Grade 2-vs-Grade 4 |
2.209400E-04 |
| Grade 3-vs-Grade 4 |
1.622800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
8.0981000000091E-05 |
| ccA subtype-vs-ccB subtype |
2.06439999539398E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.23939747354029E-11 |
| Normal-vs-N1 |
6.832300E-02 |
| N0-vs-N1 |
4.117200E-01 |
|
|
